Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-10

FDA Approved: PERINDOPRIL ERBUMINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Perindopril Erbumine from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perindopril erbumine (perindopril erbumine)

Snippet

SUPPL AP for PERINDOPRIL ERBUMINE (PERINDOPRIL ERBUMINE)